Opus Genetics, Inc. (IRD)
NASDAQ: IRD · Real-Time Price · USD
1.003
-0.007 (-0.67%)
Mar 31, 2025, 2:20 PM EDT - Market open
Opus Genetics Stock Forecast
Stock Price Forecast
The 1 analyst with a 12-month price forecast for Opus Genetics stock has a target of 8.00, which predicts an increase of 697.45% from the current stock price of 1.00.
Analyst Consensus: Strong Buy
* Price targets were last updated on Feb 19, 2025.
Analyst Ratings
According to 1 stock analyst, the rating for Opus Genetics is "Strong Buy". This means that the analyst believes this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
Rating | Feb '25 | Mar '25 |
---|---|---|
Strong Buy | 1 | 1 |
Buy | 0 | 0 |
Hold | 0 | 0 |
Sell | 0 | 0 |
Strong Sell | 0 | 0 |
Total | 1 | 1 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $8 | Strong Buy | Reiterates | $8 | +697.45% | Feb 19, 2025 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $8 | Strong Buy | Reiterates | $8 | +697.45% | Dec 12, 2024 |
Financial Forecast
Revenue This Year
9.18M
from 19.05M
Decreased by -51.82%
Revenue Next Year
13.06M
from 9.18M
Increased by 42.28%
EPS This Year
-1.14
from -0.46
EPS Next Year
-1.00
from -1.14
Revenue Forecast
Revenue | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|---|
High | 11.1M | 14.8M | 37.9M | |||
Avg | 9.2M | 13.1M | 27.2M | |||
Low | 6.9M | 12.0M | 21.7M |
Revenue Growth
Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|---|
High | -41.6% | 61.2% | 190.5% | |||
Avg | -51.8% | 42.3% | 108.6% | |||
Low | -63.7% | 30.3% | 66.4% |
EPS Forecast
EPS | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|---|
High | -1.07 | -1.00 | -0.21 | |||
Avg | -1.14 | -1.00 | -0.39 | |||
Low | -1.20 | -1.01 | -0.74 |
EPS Growth
EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|---|
High | - | - | - | |||
Avg | - | - | - | |||
Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.